| A blood RNA signature for tuberculosis disease risk: a prospective cohort study DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ... The Lancet 387 (10035), 2312-2322, 2016 | 826 | 2016 |
| Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure ST Malherbe, S Shenai, K Ronacher, AG Loxton, G Dolganov, M Kriel, ... Nature medicine 22 (10), 1094-1100, 2016 | 304 | 2016 |
| Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 286 | 2018 |
| Immunogenicity of Novel DosR Regulon-Encoded Candidate Antigens of Mycobacterium tuberculosis in Three High-Burden Populations in Africa GF Black, BA Thiel, MO Ota, SK Parida, R Adegbola, WH Boom, ... Clinical and Vaccine Immunology 16 (8), 1203-1212, 2009 | 195 | 2009 |
| Host blood RNA signatures predict the outcome of tuberculosis treatment EG Thompson, Y Du, ST Malherbe, S Shankar, J Braun, J Valvo, ... Tuberculosis 107, 48-58, 2017 | 194 | 2017 |
| Increased Frequency of Myeloid-derived Suppressor Cells during Active Tuberculosis and after Recent Mycobacterium tuberculosis Infection Suppresses T-Cell … N Du Plessis, L Loebenberg, M Kriel, F von Groote-Bidlingmaier, ... American journal of respiratory and critical care medicine 188 (6), 724-732, 2013 | 188 | 2013 |
| Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and … NN Chegou, JS Sutherland, S Malherbe, AC Crampin, PLAM Corstjens, ... Thorax 71 (9), 785-794, 2016 | 182 | 2016 |
| Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection E Nemes, V Rozot, H Geldenhuys, N Bilek, S Mabwe, D Abrahams, ... American journal of respiratory and critical care medicine 196 (5), 638-648, 2017 | 155 | 2017 |
| Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa AG Loxton, JK Knaul, L Grode, A Gutschmidt, C Meller, B Eisele, ... Clinical and Vaccine Immunology 24 (2), e00439-16, 2017 | 151 | 2017 |
| Metabolite changes in blood predict the onset of tuberculosis J Weiner 3rd, J Maertzdorf, JS Sutherland, FJ Duffy, E Thompson, ... Nature communications 9 (1), 5208, 2018 | 149 | 2018 |
| Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial TJ Scriba, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, SK Mbandi, ... The Lancet Infectious Diseases 21 (3), 354-365, 2021 | 136 | 2021 |
| Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response R Jacobs, S Malherbe, AG Loxton, K Stanley, G Van Der Spuy, G Walzl, ... Oncotarget 7 (36), 57581, 2016 | 111 | 2016 |
| Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting NN Chegou, GF Black, AG Loxton, K Stanley, PN Essone, MR Klein, ... BMC infectious diseases 12, 1-14, 2012 | 100 | 2012 |
| B cells producing type I IFN modulate macrophage polarization in tuberculosis A Bénard, I Sakwa, P Schierloh, A Colom, I Mercier, L Tailleux, L Jouneau, ... American journal of respiratory and critical care medicine 197 (6), 801-813, 2018 | 95 | 2018 |
| Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity JS Sutherland, AG Loxton, MC Haks, D Kassa, L Ambrose, JS Lee, L Ran, ... Clinical microbiology and infection 20 (4), O230-O238, 2014 | 90 | 2014 |
| Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment R Jacobs, E Tshehla, S Malherbe, M Kriel, AG Loxton, K Stanley, ... Cytokine 81, 50-56, 2016 | 80 | 2016 |
| Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area NN Chegou, PN Essone, AG Loxton, K Stanley, GF Black, ... PloS one 7 (6), e38501, 2012 | 78 | 2012 |
| Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis KG Phalane, M Kriel, AG Loxton, A Menezes, K Stanley, GD Van der Spuy, ... Mediators of inflammation 2013 (1), 981984, 2013 | 76 | 2013 |
| Epigenetics and proteomics join transcriptomics in the quest for tuberculosis biomarkers MM Esterhuyse, J Weiner 3rd, E Caron, AG Loxton, M Iannaccone, ... MBio 6 (5), 10.1128/mbio. 01187-15, 2015 | 74 | 2015 |
| Safety and immunogenicity of the adjunct therapeutic vaccine ID93+ GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo … TA Day, A Penn-Nicholson, AKK Luabeya, A Fiore-Gartland, N Du Plessis, ... The Lancet Respiratory Medicine 9 (4), 373-386, 2021 | 72 | 2021 |
